Evidence map›Paper›PMID 40632498›Full record

ArticleBriefings in bioinformatics2025

Multimodal zero-shot learning of previously unseen epitranscriptomes from RNA-seq data.

Yiyou Song, Bowen Song, Daiyun Huang, Anh Nguyen, Lihong Hu, Jia Meng, Yue Wang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yiyou SongJiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Bowen SongDepartment of Public Health, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.ORCID 0000-0002-8586-0573
Daiyun HuangWisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
Anh NguyenDepartment of Computer Sciences, University of Liverpool, Ashton Street, Liverpool L69 3BX, United Kingdom.
Lihong HuJiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Jia MengDepartment of Biological Sciences, School of Science, Suzhou Key Laboratory of Cancer Biology and Chronic Diseases, Xi'an Jiaotong-Liverpool University, 111 Ren'ai Road, Suzhou Industrial Park, Suzhou 215123, China.ORCID 0000-0003-3455-205X
Yue WangJiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.ORCID 0000-0001-6271-6547

Funding

China Academy of Chinese Medical Sciences CI2023C042LHNanjing University of Chinese Medicine 013038019029Nanjing University of Chinese Medicine 013038030001National Natural Science Foundation of China 32300552National Natural Science Foundation of China 32400527National Natural Science Foundation of China U2102201National Natural Science Foundation of China U24A20785Natural Science Foundation of Jiangsu Province BK20240723XJTLU Key Program Special Fund KSF-E-51 and KSF-P-02
6 · The paper itself

Abstract

Precise identification of condition-specific epitranscriptomes is of critical importance for investigating the dynamics and versatile functions of RNA modification under various biological contexts. Existing approaches for predicting condition-specific RNA modification are usually trained on epitranscriptome data obtained from the same condition, which limited their usage, as such data are available only for a small number of conditions due to the technical difficulties and high expenses of epitranscriptome profiling technologies. We present ExpressRM, a multimodal zero-shot learning framework for predicting condition-specific RNA modification sites in previously unseen contexts from genome and RNA-seq data. Different from existing in-condition learning approaches, this method does not rely on matched epitranscriptome data for training, which greatly expands its applicability. On a benchmark dataset comprising epitranscriptomes and matched transcriptomes of 37 human tissues, we demonstrate that ExpressRM can accurately predict epitranscriptomes of previously unseen conditions from their transcriptomes only, and the performance is comparable to existing in-condition learning algorithms that require epitranscriptome data from the same condition. Additionally, the method has the capability of differentiating highly dynamic RNA methylation sites from more static (or house-keeping) ones. With a case study, we show that ExpressRM can uncover N6-methyladenosine RNA methylation sites in glioblastoma using only its RNA-seq data, and unveils novel and previously validated pathological insights. Together, these results suggest that the proposed multimodal zero-shot learning framework can effectively leverage transcriptome knowledge to explore the dynamic roles of RNA modifications in previously unseen experimental setups, providing valuable insights into vast biological contexts where RNA-seq is routinely used but epitranscriptome profiling has not yet been covered.

Indexed as

Epigenesis, GeneticMachine LearningRNA-SeqTranscriptomeAlgorithmsComputational BiologyHumansRNASequence Analysis, RNARNAcondition-specificityepitranscriptomem6Amulti-modalRNA modificationzero-shot learning

Identifiers

PMID40632498
PMCPMC12239634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.